BrightSpring Health Services, Inc. Common Stock (BTSG) P/E Ratio History
ExpensiveTrading at 77.2x vs 5Y avg 51.6x · 100th percentile · Material premium to history · Data 2025–2026
Loading P/E history...
P/E Ratio Analysis
As of November 8, 2026, BrightSpring Health Services, Inc. Common Stock (BTSG) trades at a price-to-earnings ratio of 77.2x, with a stock price of $67.15 and trailing twelve-month earnings per share of $1.54.
The current P/E is 50% above its 5-year average of 51.6x. Over the past five years, BTSG's P/E has ranged from a low of 37.1x to a high of 76.5x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Healthcare sector median P/E of 25.1x, BTSG trades at a 208% premium to its sector peers. The sector includes 229 companies with P/E ratios ranging from 0.0x to 195.0x.
The PEG ratio of 1.59 (P/E divided by 1029% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, BTSG commands a significant premium over the S&P 500 median P/E of 26.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BTSG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BTSG Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
BTSG P/E vs Peers
Drug Distributors & Pharmacies peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $5B | 688.5 | - | +113%Best | |
| $11B | 31.0 | 2.25 | +14% | |
| $2B | 23.9 | 1.18Best | +23% | |
| $5B | 24.9 | - | +3% | |
| $2B | 30.0 | - | +53% | |
| $2B | 14.0Lowest | - | -29% | |
| $126B | 27.6 | - | +49% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
BTSG Historical P/E Data (2025–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q3 | Sep 30 2026 | $56.75 | $1.53 | 37.1x | -28% |
| FY2026 Q2 | - | $69.74 | $1.34 | 52.0x | +1% |
| FY2026 Q1 | - | $42.61 | $1.08 | 39.5x | -24% |
| FY2025 Q4 | Dec 31 2025 | $37.45 | $0.88 | 42.6x | -17% |
| FY2025 Q3 | - | $29.56 | $0.61 | 48.5x | -6% |
| FY2025 Q2 | Jun 30 2025 | $23.59 | $0.31 | 76.5x | +48% |
| FY2025 Q1 | Mar 31 2025 | $18.09 | $0.28 | 65.0x | +26% |
Average P/E for displayed period: 51.6x
BTSG Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
1+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BTSG — Frequently Asked Questions
Quick answers to the most common questions about buying BTSG stock.
What is BTSG's P/E ratio?
BrightSpring Health Services, Inc. Common Stock (BTSG) trailing twelve-month P/E ratio is 77.2x, based on TTM diluted EPS of $1.54. The 5-year average P/E is 51.6x and the historical range spans 37.1x to 76.5x.
Is BTSG stock overvalued or undervalued?
BTSG trades at 77.2x P/E, above its 5-year average of 51.6x. The 100th percentile ranking within the 37.1x–76.5x historical range indicates a premium to historical valuation.
Is BTSG stock expensive?
Yes, BTSG is expensive relative to its own history. The current P/E of 77.2x is above the 5-year average of 51.6x and also above the Healthcare sector median of 25.1x. The stock sits at the 100th percentile of its 5-year valuation range.
What is BTSG's historical P/E range?
Over the past 5 years, BTSG's P/E ratio has ranged from 37.1x to 76.5x, with a median of 48.5x and an average of 51.6x. The current P/E of 77.2x places the stock at the 100th percentile of this range. Full historical data spans 2025–2026.
How does BTSG's P/E compare to the S&P 500?
BTSG trades at 77.2x P/E versus the S&P 500 median of 26.3x. The 194% premium to the market typically reflects higher expected earnings growth or quality.
How does BTSG's valuation compare to Healthcare peers?
BrightSpring Health Services, Inc. Common Stock P/E of 77.2x compares to the Healthcare sector median of 25.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is BTSG's PEG ratio?
BTSG PEG ratio is 1.59, based on a P/E of 77.2x and EPS growth of 1029.5%. A PEG between 1 and 2 suggests valuation aligns with growth expectations — typically considered fair.
What is BTSG's earnings yield?
BTSG earnings yield is 1.30%, the inverse of its 77.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.